H1 | Amgen | A Worldwide Pioneer in Biotechnology |
H2 | A Journey to Inclusion During Asian American Pacific Islander Month |
H2 | Amgen Announces 2024 First Quarter Financial Results |
H2 | Getting Older and Still Standing Tall |
H2 | How Amgen's Real-World Evidence Is Changing The Future of Patient Care in Psoriatic Disease |
H2 | First Cancer Diagnosis Led to a Dark Place—Aiding Another Helped Lift Him Out of It |
H2 | Navigating the Landscape of Precision Medicine in Gastric Cancer: FGFR2b Protein Overexpression as an Emerging Biomarker |
H2 | Amgen CEO Bob Bradway's 2023 Letter to Shareholders |
H2 | How the LATTICE™ Consortium Is Igniting Action and Innovation in Cardiovascular Care |
H2 | That Ref on Amgen Court? He Also Refs College Hoops and Once Did a Game Featuring an NBA Star |
H2 | Three Amgen Leaders Honored for Exceptional Leadership and Mentorship |
H2 | Jean-Charles Soria Elected to American Association for Cancer Research Board of Directors |
H2 | Mastering the Art of Cooking and Life Without Sight |
H2 | Building Trust with the Black Community |
H2 | “Very Exciting” Future for Cancer Research, Bradway Says at “Business of Biotech” Conference |
H2 | Visit Our KRAS G12C Information Center |
H2 | Our Story |
H2 | Our Science |
H2 | Our Products |
H2 | Our Responsibility |
H2 | Amgen Investors |
H2 | Careers With Amgen |
H3 | Our Latest Press Releases |
H3 | Follow Us On Social Media |
H5 | Global hotline for Ukrainian refugee patients participating in an Amgen clinical trial. |
H5 | Click here for more information. |